| 今开：1.76 | 昨收：1.78 |
| 最高：1.83 | 最低：1.55 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.9148878E7 |
BioSig Technologies(BSGM)02-22 05:15
$BioSig Technologies(BSGM)$ 8-K Current report, item 5.02 Accession Number: 0001493152-24-007392 Act: 34 Size: 208 KB 网页链接查看全文
BioSig Technologies(BSGM)05-03 20:35
$BioSig Technologies(BSGM)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001493152-24-017634 Act: 34 Size: 239 KB 网页链接查看全文
BioSig Technologies(BSGM)03-05 09:05
$BioSig Technologies(BSGM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-008758 Size: 5 KB 网页链接查看全文
BioSig Technologies(BSGM)03-11 21:05
$BioSig Technologies(BSGM)$ 8-K Current report, item 3.01 Accession Number: 0001493152-24-009494 Act: 34 Size: 210 KB 网页链接查看全文
BioSig Technologies(BSGM)02-06 21:45
$BioSig Technologies(BSGM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-24-005030 Act: 34 Size: 247 KB 网页链接查看全文
BioSig Technologies(BSGM)03-12 21:45
$BioSig Technologies(BSGM)$ 8-K Current report, item 1.01 Accession Number: 0001493152-24-009635 Act: 34 Size: 364 KB 网页链接查看全文
BioSig Technologies(BSGM)04-17 05:15
$BioSig Technologies(BSGM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-014860 Act: 34 Size: 11 MB 网页链接查看全文
BioSig Technologies(BSGM)03-18 18:15
$BioSig Technologies(BSGM)$ 8-K Current report, item 3.01 Accession Number: 0001493152-24-010175 Act: 34 Size: 216 KB 网页链接查看全文
BioSig Technologies(BSGM)04-02 20:05
$BioSig Technologies(BSGM)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001493152-24-012634 Act: 34 Size: 42 KB 网页链接查看全文
BioSig Technologies(BSGM)03-12 03:35
$BioSig Technologies(BSGM)$ 144 Report of proposed sale of securities Accession Number: 0001949846-24-000154 Act: 33 Size: 4 KB 网页链接查看全文
啃医药股的熊猫2019-05-10 14:06
【汇众医疗】生物技术股票前瞻：全球眼科学市场收入将于2022年高达260亿美元
眼科学公司Guardion Health Sciences微粒化液体配方Lumega-Z对年龄相关性黄斑部视力疾病显示出临床效益；$BIOSIG TECHNOLOGIE(BSGM)$ BioSig科技公司成功记录消融过程所传到的清晰信号。 查看全文网页链接查看全文
用户48783635432019-05-10 13:21
【汇众医疗】生物技术股票前瞻：全球眼科学市场收入将于2022年高达260亿美元，$Guardion健康科学(GHSI)$ 眼科学公司Guardion Health Sciences微粒化液体配方Lumega-Z对年龄相关性黄斑部视力疾病显示出临床效益；$BIOSIG TECHNOLOGIE(BSGM)$ BioSig科技公司成功记录消融过程所传到的清晰信号。 查看...查看全文
用户48783635432019-02-22 11:09
【介绍几家电疗公司】预计2029年生物电子医药市场规模将超600亿美元
$BIOSIG TECHNOLOGIE(BSGM)$$Nuvectra(NVTR)$ $波士顿科学(BSX)$ BioSig是一家开发专用生物医学信号处理平台的医疗设备公司，最近宣布，公司成功地使用 PURE EP ™系统进行了第一例患者病例的治疗， FDA 已批准其专有信号采...查看全文
BioSig Technologies(BSGM.US)获Ascendiant Capital首次覆盖，给予买入评级,目标价5.00美元。 BioSig Technologies(BSGM.US)公司简介：BioSig Technologies Inc是一家医疗技术公司。该公司正在商业化一种专有的生物医学信号处理平台，该平台... 网页链接
$BioSig Technologies(BSGM)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-23-039894 Act: 34 Size: 229 KB 网页链接
$BioSig Technologies(BSGM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-23-039647 Act: 34 Size: 237 KB 网页链接
$BioSig Technologies(BSGM)$ DEF 14A Other definitive proxy statements Accession Number: 0001185185-23-001137 Act: 34 Size: 1 MB 网页链接
$BioSig Technologies(BSGM)$ ARS Annual Report to Security Holders Accession Number: 0001185185-23-001138 Act: 34 Size: 1 MB 网页链接
$BioSig Technologies(BSGM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001185185-23-001139 Act: 34 Size: 226 KB 网页链接
$BioSig Technologies(BSGM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001185185-23-001127 Act: 34 Size: 191 KB 网页链接
$BioSig Technologies(BSGM)$ 8-K Current report, item 1.02 Accession Number: 0001185185-23-001126 Act: 34 Size: 158 KB 网页链接
$BioSig Technologies(BSGM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001185185-23-001120 Act: 34 Size: 187 KB 网页链接
$BioSig Technologies(BSGM)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001185185-23-001100 Act: 33 Size: 16 KB 网页链接
$BioSig Technologies(BSGM)$ PRE 14A Other preliminary proxy statements Accession Number: 0001185185-23-001097 Act: 34 Size: 1 MB 网页链接